69 research outputs found
Shelfâbasin exchange times of Arctic surface waters estimated from \u3csup\u3e228\u3c/sup\u3eTH/\u3csup\u3e228\u3c/sup\u3eRa disequilibrium
The transpolar drift is strongly enriched in 228Ra accumulated on the wide Arctic shelves with subsequent rapid offshore transport. We present new data of Polarstern expeditions to the central Arctic and to the Kara and Laptev seas. Because 226Ra activities in Pacific waters are 30% higher than in Atlantic waters, we correct 226Ra for the Pacific admixture when normalizing 228Ra with 226Ra. The use of 228Ra decay as age marker critically depends on the constancy in space and time of the source activity, a condition that has not yet adequately been tested. While 228Ra decays during transit over the central basin, ingrowth of 228Th could provide an alternative age marker. The high 228Th/228Ra activity ratio (AR = 0.8â1.0) in the central basins is incompatible with a mixing model based on horizontal eddy diffusion. An advective model predicts that 228Th grows to an equilibrium AR, the value of which depends on the scavenging regime. The low AR over the Lomonosov Ridge (AR = 0.5) can be due to either rapid transport (minimum age without scavenging 1.1 year) or enhanced scavenging. Suspended particulate matter load (derived from beam transmission and particulate 234Th) and total 234Th depletion data show that scavenging, although extremely low in the central Arctic, is enhanced over the Lomonosov Ridge, making an age of 3 years more likely. The combined data of 228Ra decay and 228Th ingrowth confirm the existence of a recirculating gyre in the surface water of the eastern Eurasian Basin with a river water residence time of at least 3 year
226Ra, 228Ra and 40K as tracers of erosion and accumulation processes: A 3-year study on a beach with different sediment dynamics
The aim of this study is to analyse the role of natural radionuclides 226Ra, 228Ra, 40K and unsupported 210Pb (210Pbex), as erosion and accumulation process tracers. For this purpose, a complex system, including both the characteristic dynamics of a closed beach and those associated with a beach open to wave action, was studied. A 3-year study of monthly variation of 226Ra, 228Ra, 40K and 210Pbex was carried out at Las Canteras beach, on the Island of Gran Canaria (Spain), covering several erosion and accumulation periods. A correlation analysis, ANOVA test and Tukeyâs Honestly Significant Difference (HSD) Test proved that the marine erosion and accumulation agents influenced the activity concentration values found for the different radionuclides. Moreover, the geochemical analysis of samples from maximum and minimum activity concentration values showed that the natural radionuclides studied could be suitable tracers for studying beach sediment dynamics in erosion and accumulation periods
Chronic Kidney Disease and Nonalcoholic Fatty Liver DiseaseâIs There a Link?
Research in recent years has led to the recognition of the importance of nonalcoholic fatty liver disease (NAFLD) and its relationship to the metabolic syndrome (MS). This has led to a growing interest in the potential prognostic value of NAFLD for adverse cardiovascular disease (CVD) outcome. On the other hand, searching for new risk factors for chronic kidney disease (CKD) development and progression is very important. Growing evidence suggests that the MS is an important factor in the pathogenesis of CKD. The best confirmation of this pathogenic link is hypertensive and diabetic nephropathy as the main causes of CKD. Furthermore, the possible link between NAFLD and CKD has also attracted research interest and recent data suggest an association between these two conditions. These findings have fuelled concerns that NAFLD may be a new and added risk factor for the development and progression of CKD. NAFLD and CKD share some important cardiometabolic risk factors and possible common pathophysiological mechanisms, and both are linked to an increased risk of incident CVD events. Therefore, common factors underlying the pathogenesis of NAFLD and CKD may be insulin resistance, oxidative stress, activation of rennin-angiotensin system, and inappropriate secretion of inflammatory cytokines by steatotic and inflamed liver
Ustekinumab as Induction and Maintenance Therapy for Crohnâs Disease
BACKGROUND
Ustekinumab, a monoclonal antibody to the p40 subunit of interleukin-12 and inter-leukin-23, was evaluated as an intravenous induction therapy in two populations with moderately to severely active Crohnâs disease. Ustekinumab was also evaluated as subcutaneous maintenance therapy.
METHODS
We randomly assigned patients to receive a single intravenous dose of ustekinumab (either 130 mg or approximately 6 mg per kilogram of body weight) or placebo in two induction trials. The UNITI-1 trial included 741 patients who met the criteria for primary or secondary nonresponse to tumor necrosis factor (TNF) antagonists or had unacceptable side effects. The UNITI-2 trial included 628 patients in whom conventional therapy failed or unacceptable side effects occurred. Patients who completed
these induction trials then participated in IM-UNITI, in which the 397 patients who had a response to ustekinumab were randomly assigned to receive subcutaneous maintenance injections of 90 mg of ustekinumab (either every 8 weeks or every 12 weeks) or placebo. The primary end point for the induction trials was a clinical response at week 6 (defined as a decrease from baseline in the Crohnâs Disease Activity Index [CDAI] score of â„100 points or a CDAI score <150). The primary end point for the maintenance trial was remission at week 44 (CDAI score <150).
RESULTS
The rates of response at week 6 among patients receiving intravenous ustekinumab at a dose of either 130 mg or approximately 6 mg per kilogram were significantly higher
than the rates among patients receiving placebo (in UNITI-1, 34.3%, 33.7%, and 21.5%, respectively, with Pâ€0.003 for both comparisons with placebo; in UNITI-2, 51.7%, 55.5%, and 28.7%, respectively, with P<0.001 for both doses). In the groups receiving maintenance doses of ustekinumab every 8 weeks or every 12 weeks, 53.1% and 48.8%, respectively, were in remission at week 44, as compared with 35.9% of those receiving placebo (P = 0.005 and P = 0.04, respectively). Within each trial, adverse-event rates were similar among treatment groups.
CONCLUSIONS
Among patients with moderately to severely active Crohnâs disease, those receiving intravenous ustekinumab had a significantly higher rate of response than did those receiving placebo. Subcutaneous ustekinumab maintained remission in patients who had a clinical response to induction therapy. (Funded by Janssen Research and Development; ClinicalTrials.gov numbers, NCT01369329, NCT01369342, and NCT01369355.
Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis
Metastatic epidural spinal cord compression: current concepts and treatment
Metastatic epidural spinal cord compression (MESCC) is a medical emergency complicating the course of 5â10% of patients with cancer [1]. When diagnosis and treatment is early with the patient ambulatory prognosis for continued ambulation is good [2]. If the patient is nonambulatory or paraplegic, prognosis for meaningful recovery of motor and bladder function is markedly decreased. In the last decade, significant advances in the understanding, management and treatment of metastatic epidural spinal cord compression have occurred.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/45378/1/11060_2005_Article_BF01051052.pd
Neutrophil â Lymphocyte ratio â A new score for predicting complications in patients with acute pancreatitis
Chemotherapy in patients with nonresectable cancer of the biliary system or advanced gallbladder cancer: Do elderly have benefit at all?
Dating Deep-Sea Sediments With 230Th Excess Using a Constant Rate of Supply Model
We present a dating method for deep-sea sediments that uses the natural radionuclide 230Th (half-life 75,380 years) in analogy to 210Pb with the constant rate of supply (CRS) model. Using an example from the western Indian sector of the Southern Ocean, we demonstrate how sets of values of 230Th, 232Th, and U isotopes activities can supply absolute age information for the last ~450,000 years, given a sufficient precision, resolution, and depth coverage of the analytical data in a suitable core. An assessment of age uncertainties resulting from analytical errors using a Monte Carlo approach and an analytical solution for error propagation shows good agreement. We also investigate errors due to a violation of model assumptions by variable focusing of deep-sea sediments by means of a simulated core. Finally, we use real examples from independently dated sediment cores containing carbonate, using previously existing 230Th data, to test the approach. The consideration of the systematic errors and the examples suggests that the uncertainties are smallest in the central part of the record and that the variability of focusing conditions controls the accuracy of the 230Th CRS dates. Our own example demonstrates an excellent agreement of the 230Th CRS method with independent age constraints, adding an important tool for dating marine records that does not depend on the presence of carbonate. The obtained values are also suitable to calculate 230Th-normalized preserved vertical rain rates of various sedimentary compounds, permitting an improved quantitative comparison of marine paleorecords with other archives like ice cores
C202: A rare case of squamous cell carcinoma in urinary bladder diverticulum successfully treated by bladder - sparing surgery
- âŠ